Ilana Traynis1, Carlos G De Moraes2, Ali S Raza3, Jeffrey M Liebmann2, Robert Ritch4, Donald C Hood5. 1. Department of Psychology, Columbia University, New York, New York2Tufts University School of Medicine, Boston, Massachusetts. 2. Einhorn Clinical Research Center, New York Eye and Ear Infirmary, New York, New York5Department of Ophthalmology, New York University School of Medicine, New York, New York. 3. Department of Psychology, Columbia University, New York, New York. 4. Einhorn Clinical Research Center, New York Eye and Ear Infirmary, New York, New York6Department of Ophthalmology, New York Medical College, Valhalla, New York. 5. Department of Psychology, Columbia University, New York, New York3Department of Ophthalmology, Columbia University, New York, New York.
Abstract
IMPORTANCE: The macula is essential for visual functioning and is known to be affected even in early glaucoma. However, little is currently understood about the prevalence and nature of central vision loss in early glaucoma. OBJECTIVE: To determine the prevalence and characteristics of visual field (VF) defects in the central 10° in glaucoma suspects and patients with mild glaucoma using a prospective design. DESIGN, SETTING, AND PARTICIPANTS: This prospective observational cohort study was conducted at an outpatient glaucoma specialty clinic. One hundred eyes from 74 patients with glaucomatous optic neuropathy and a 24-2 VF with mean deviation better than -6 dB were prospectively studied and tested with a 10-2 test. MAIN OUTCOMES AND MEASURES: Reliable: VF hemifields were classified as abnormal based on a cluster criterion, and abnormal 10-2 VFs were categorized based on the pattern of abnormal points: arcuatelike, widespread, or other. In addition, at each point of the 10-2 VF, the total deviation values were averaged across eyes and the number of abnormal points with total deviation values below a specific criterion level were calculated. RESULTS There appeared to be as many abnormal 10-2 hemifields (53%) as abnormal 24-2 hemifields (59%). Of the eyes with normal 24-2 hemifields, 16% were classified as abnormal when the 10-2 test was used. Of the abnormal 10-2 hemifields, 68%, 8%, and 25% were arcuatelike, widespread, and other, respectively. The average total deviation values and number of abnormal points plots revealed superior VF defects that were deeper and closer to fixation than those in the inferior VF. CONCLUSIONS AND RELEVANCE: The 10-2 VF was abnormal in nearly as many hemifields as was the 24-2 VF, including some with normal 24-2 VF, suggesting that the 24-2 test is not optimal for detecting early damage of the macula. The pattern of the defects was in agreement with a recent model of macular damage.
IMPORTANCE: The macula is essential for visual functioning and is known to be affected even in early glaucoma. However, little is currently understood about the prevalence and nature of central vision loss in early glaucoma. OBJECTIVE: To determine the prevalence and characteristics of visual field (VF) defects in the central 10° in glaucoma suspects and patients with mild glaucoma using a prospective design. DESIGN, SETTING, AND PARTICIPANTS: This prospective observational cohort study was conducted at an outpatientglaucoma specialty clinic. One hundred eyes from 74 patients with glaucomatous optic neuropathy and a 24-2 VF with mean deviation better than -6 dB were prospectively studied and tested with a 10-2 test. MAIN OUTCOMES AND MEASURES: Reliable: VF hemifields were classified as abnormal based on a cluster criterion, and abnormal 10-2 VFs were categorized based on the pattern of abnormal points: arcuatelike, widespread, or other. In addition, at each point of the 10-2 VF, the total deviation values were averaged across eyes and the number of abnormal points with total deviation values below a specific criterion level were calculated. RESULTS There appeared to be as many abnormal 10-2 hemifields (53%) as abnormal 24-2 hemifields (59%). Of the eyes with normal 24-2 hemifields, 16% were classified as abnormal when the 10-2 test was used. Of the abnormal 10-2 hemifields, 68%, 8%, and 25% were arcuatelike, widespread, and other, respectively. The average total deviation values and number of abnormal points plots revealed superior VF defects that were deeper and closer to fixation than those in the inferior VF. CONCLUSIONS AND RELEVANCE: The 10-2 VF was abnormal in nearly as many hemifields as was the 24-2 VF, including some with normal 24-2 VF, suggesting that the 24-2 test is not optimal for detecting early damage of the macula. The pattern of the defects was in agreement with a recent model of macular damage.
Authors: Sung Chul Park; Carlos Gustavo De Moraes; Christopher C W Teng; Celso Tello; Jeffrey M Liebmann; Robert Ritch Journal: Ophthalmology Date: 2011-06-12 Impact factor: 12.079
Authors: Donald C Hood; Ali S Raza; Carlos Gustavo V de Moraes; Jeffrey M Liebmann; Robert Ritch Journal: Prog Retin Eye Res Date: 2012-09-17 Impact factor: 21.198
Authors: Ali S Raza; Jungsuk Cho; Carlos G V de Moraes; Min Wang; Xian Zhang; Randy H Kardon; Jeffrey M Liebmann; Robert Ritch; Donald C Hood Journal: Arch Ophthalmol Date: 2011-12
Authors: Donald C Hood; Ali S Raza; Carlos Gustavo V de Moraes; Jeffrey G Odel; Vivienne C Greenstein; Jeffrey M Liebmann; Robert Ritch Journal: Invest Ophthalmol Vis Sci Date: 2011-02-16 Impact factor: 4.799
Authors: Paul H Artes; Balwantray C Chauhan; John L Keltner; Kim E Cello; Chris A Johnson; Douglas R Anderson; Mae O Gordon; Michael A Kass Journal: Arch Ophthalmol Date: 2010-12
Authors: John L Keltner; Chris A Johnson; Kimberly E Cello; Mary A Edwards; Shannan E Bandermann; Michael A Kass; Mae O Gordon Journal: Arch Ophthalmol Date: 2003-05
Authors: Donald C Hood; Anastasia Slobodnick; Ali S Raza; Carlos Gustavo de Moraes; Christopher C Teng; Robert Ritch Journal: Invest Ophthalmol Vis Sci Date: 2014-02-03 Impact factor: 4.799
Authors: Caitlin O'Connell; Leon C Ho; Matthew C Murphy; Ian P Conner; Gadi Wollstein; Rakie Cham; Kevin C Chan Journal: Neuroreport Date: 2016-11-09 Impact factor: 1.837
Authors: Shawn Philip; Ahmad Najafi; Apichat Tantraworasin; Toco Y P Chui; Richard B Rosen; Robert Ritch Journal: Invest Ophthalmol Vis Sci Date: 2019-03-01 Impact factor: 4.799
Authors: Liang Liu; Ou Tan; Eliesa Ing; John C Morrison; Beth Edmunds; Ellen Davis; Seema Gupta; Lorinna H Lombardi; Yali Jia; David Huang Journal: Am J Ophthalmol Date: 2019-11-23 Impact factor: 5.258
Authors: Carlos Gustavo De Moraes; Ashley Sun; Ravivarn Jarukasetphon; Rashmi Rajshekhar; Lynn Shi; Dana M Blumberg; Jeffrey M Liebmann; Robert Ritch; Donald C Hood Journal: JAMA Ophthalmol Date: 2019-02-01 Impact factor: 7.389
Authors: Alisa J Prager; Donald C Hood; Jeffrey M Liebmann; C Gustavo De Moraes; Lama A Al-Aswad; Qi Yu; George A Cioffi; Dana M Blumberg Journal: JAMA Ophthalmol Date: 2017-07-01 Impact factor: 7.389
Authors: Aakriti G Shukla; C Gustavo De Moraes; George A Cioffi; Christopher A Girkin; Robert N Weinreb; Linda M Zangwill; Jeffrey M Liebmann Journal: J Glaucoma Date: 2020-06 Impact factor: 2.503